572 related articles for article (PubMed ID: 17655810)
1. Elimination of sevoflurane is reduced in plasma-tight compared to conventional membrane oxygenators.
Prasser C; Zelenka M; Gruber M; Philipp A; Keyser A; Wiesenack C
Eur J Anaesthesiol; 2008 Feb; 25(2):152-7. PubMed ID: 17655810
[TBL] [Abstract][Full Text] [Related]
2. Reduced sevoflurane loss during cardiopulmonary bypass when using a polymethylpentane versus a polypropylene oxygenator.
Hinz J; Molder JM; Hanekop GG; Weyland A; Popov AF; Bauer M; Kazmaier S
Int J Artif Organs; 2013 Apr; 36(4):233-9. PubMed ID: 23504814
[TBL] [Abstract][Full Text] [Related]
3. In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass.
Wiesenack C; Wiesner G; Keyl C; Gruber M; Philipp A; Ritzka M; Prasser C; Taeger K
Anesthesiology; 2002 Jul; 97(1):133-8. PubMed ID: 12131114
[TBL] [Abstract][Full Text] [Related]
4. Changes in sevoflurane plasma concentration with delivery through the oxygenator during on-pump cardiac surgery.
Nitzschke R; Wilgusch J; Kersten JF; Trepte CJ; Haas SA; Reuter DA; Goetz AE; Goepfert MS
Br J Anaesth; 2013 Jun; 110(6):957-65. PubMed ID: 23462192
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial on the effect of sevoflurane on polypropylene membrane oxygenator performance.
Nigro Neto C; Arnoni R; Rida BS; Landoni G; Tardelli MA
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):903-7. PubMed ID: 23725688
[TBL] [Abstract][Full Text] [Related]
6. Desflurane and sevoflurane concentrations in blood passing through the oxygenator during cardiopulmonary bypass: a randomized prospective pilot study.
Tamura T; Mori A; Ishii A; Ando M; Kubo Y; Nishiwaki K
J Anesth; 2020 Dec; 34(6):904-911. PubMed ID: 32851513
[TBL] [Abstract][Full Text] [Related]
7. Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting.
Hemmerling T; Olivier JF; Le N; Prieto I; Bracco D
Eur J Anaesthesiol; 2008 Mar; 25(3):230-6. PubMed ID: 17894911
[TBL] [Abstract][Full Text] [Related]
8. The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass.
Cho EJ; Yoon JH; Hong SJ; Lee SH; Sim SB
J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):639-45. PubMed ID: 19362013
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of sevoflurane, isoflurane, and propofol in coronary surgery patients: a randomized controlled study.
Yildirim V; Doganci S; Aydin A; Bolcal C; Demirkilic U; Cosar A
Heart Surg Forum; 2009 Jan; 12(1):E1-9. PubMed ID: 19233758
[TBL] [Abstract][Full Text] [Related]
10. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol.
Bein B; Renner J; Caliebe D; Hanss R; Bauer M; Fraund S; Scholz J
Anaesthesia; 2008 Oct; 63(10):1046-55. PubMed ID: 18627368
[TBL] [Abstract][Full Text] [Related]
11. Sevoflurane and Isoflurane-Pharmacokinetics, Hemodynamic Stability, and Cardioprotective Effects During Cardiopulmonary Bypass.
Freiermuth D; Mets B; Bolliger D; Reuthebuch O; Doebele T; Scholz M; Gregor M; Haschke M; Seeberger MD; Fassl J
J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1494-1501. PubMed ID: 27692704
[TBL] [Abstract][Full Text] [Related]
12. Monitoring anaesthetic gas concentrations in the exhaust of the cardiopulmonary bypass oxygenator.
Hendrickx JF; Carette R; Peyton P; De Wolf A;
Br J Anaesth; 2014 Jan; 112(1):173. PubMed ID: 24318706
[No Abstract] [Full Text] [Related]
13. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery.
Frässdorf J; Borowski A; Ebel D; Feindt P; Hermes M; Meemann T; Weber R; Müllenheim J; Weber NC; Preckel B; Schlack W
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1436-42, 1442.e1-2. PubMed ID: 19464461
[TBL] [Abstract][Full Text] [Related]
14. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
[TBL] [Abstract][Full Text] [Related]
15. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
16. Monitoring oxygenator expiratory isoflurane concentrations and the bispectral index to guide isoflurane requirements during cardiopulmonary bypass.
Liu EH; Dhara SS
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):485-7. PubMed ID: 16085254
[TBL] [Abstract][Full Text] [Related]
17. Membrane and bubble oxygenator: a clinical comparison in patients undergoing aortocoronary bypass procedures.
Alon L; Turina M; Gattiker R
Herz; 1979 Feb; 4(1):56-62. PubMed ID: 108187
[TBL] [Abstract][Full Text] [Related]
18. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators.
Edmunds LH; Ellison N; Colman RW; Niewiarowski S; Rao AK; Addonizio VP; Stephenson LW; Edie RN
J Thorac Cardiovasc Surg; 1982 Jun; 83(6):805-12. PubMed ID: 7087507
[TBL] [Abstract][Full Text] [Related]
19. Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study.
Hessel EA; Johnson DD; Ivey TD; Miller DW
J Thorac Cardiovasc Surg; 1980 Jul; 80(1):111-22. PubMed ID: 6966720
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Anesthesia Maintenance With Sevoflurane During Cardiopulmonary Bypass: A Pilot Pharmacokinetics Study.
Meroni R; Gianni S; Guarnieri M; Saglietti F; Gemma M; Zangrillo A; Bignami E
J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1210-1217. PubMed ID: 28283250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
